Literature DB >> 25397738

Effect of initial empiric antibiotic therapy combined with control of the infection focus on the prognosis of patients with secondary peritonitis.

Estela Membrilla-Fernández1, Juan J Sancho-Insenser, Meritxell Girvent-Montllor, Francisco Álvarez-Lerma, Antonio Sitges-Serra.   

Abstract

BACKGROUND: In patients with intra-abdominal infection, inappropriate initial empiric antibiotic therapy is associated with greater morbidity. We evaluated the impact of adequate empiric antibiotic treatment together with control of the infection focus on the morbidity and mortality rates of patients with secondary peritonitis.
METHODS: This was a prospective, observational study with the participation of 24 Spanish hospitals and 362 patients with secondary peritonitis (262 community-acquired, 100 post-operative). Therapeutic failure (infectious complications or death) was classified into four categories according to whether empiric antibiotic treatment was appropriate and the infection focus was controlled.
RESULTS: The rates of therapeutic failure, re-operation, and mortality were 48%, 13%, and 8%, respectively. Empiric antibiotic treatment was inappropriate in 39% of cases, which was associated with a higher rate of surgical site infection (53% vs. 40%; p=0.031) and death (12% vs. 5%; p=0.021) than was observed in patients receiving appropriate initial empiric therapy. Eight percent of patients in whom control of the infection focus was not obtained suffered from more infectious complications (76% vs. 52%; p=0.01) and surgical site infections (69% vs. 44%; p=0.01); and in this group, both therapeutic failure and mortality rates were similar, independent of whether the empiric antibiotic therapy was appropriate.
CONCLUSION: Inappropriate initial empiric antibiotic therapy was associated with higher rates of therapeutic failure, surgical site infection, re-operation, and death. Classification of therapeutic failure into four categories according to the appropriateness of empiric antibiotic therapy and the success of infection control provided excellent discrimination of morbidity and death.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25397738     DOI: 10.1089/sur.2013.240

Source DB:  PubMed          Journal:  Surg Infect (Larchmt)        ISSN: 1096-2964            Impact factor:   2.150


  3 in total

1.  Antimicrobial Susceptibilities of Aerobic and Facultative Gram-Negative Bacilli from Intra-abdominal Infections in Patients from Seven Regions in China in 2012 and 2013.

Authors:  Hui Zhang; Qiwen Yang; Kang Liao; Yuxing Ni; Yunsong Yu; Bijie Hu; Ziyong Sun; Wenxiang Huang; Yong Wang; Anhua Wu; Xianju Feng; Yanping Luo; Zhidong Hu; Yunzhuo Chu; Shulan Chen; Bin Cao; Jianrong Su; Bingdong Gui; Qiong Duan; Shufang Zhang; Haifeng Shao; Haishen Kong; Robert E Badal; Yingchun Xu
Journal:  Antimicrob Agents Chemother       Date:  2015-10-19       Impact factor: 5.191

2.  Appropriateness of Empirical Fluoroquinolones Therapy in Patients Infected with Escherichia coli, Klebsiella pneumoniae, or Pseudomonas aeruginosa: The Importance of the CLSI Breakpoints Revision.

Authors:  Ying Wang; Xinping Zhang; Xuemei Wang; Xiaoquan Lai
Journal:  Infect Drug Resist       Date:  2021-08-31       Impact factor: 4.003

3.  Antibiotic sensitivity in correlation to the origin of secondary peritonitis: a single center analysis.

Authors:  Rainer Grotelüschen; Lena M Heidelmann; Marc Lütgehetmann; Nathaniel Melling; Matthias Reeh; Tarik Ghadban; Anna Dupree; Jakob R Izbicki; Kai A Bachmann
Journal:  Sci Rep       Date:  2020-10-29       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.